Fingerprint
Dive into the research topics of 'Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma
Yasuhiro Oki, Barbara Pro, Luis E. Fayad, Jorge Romaguera, Felipe Samaniego, Fredrick Hagemeister, Sattva Neelapu, Peter McLaughlin, Andre Goy, Anas Younes
Research output: Contribution to journal › Article › peer-review
68
Scopus
citations